Interleukin-12 Expression Stimulant

An "Interleukin-12 expression stimulant" refers to any molecule, compound, or biological agent that increases the production or secretion of interleukin-12 (IL-12), a key pro-inflammatory cytokine. IL-12 is primarily produced by antigen-presenting cells such as dendritic cells and macrophages in response to pathogens or immune stimuli. IL-12 acts as a critical bridge between innate and adaptive immunity. Its main functions include: inducing differentiation of naïve T cells into Th1 cells, stimulating natural killer (NK) cell activity, enhancing cytotoxic T lymphocyte (CTL) responses, and promoting the production of interferon-gamma (IFN‑γ) and tumor necrosis factor-alpha (TNF‑α). These activities make IL‑12 central to anti-microbial defense, anti-tumor immunity, and modulation of immune responses.

Stimulates the production or secretion of interleukin-12 (IL-12) by targeting various pathways, including Toll-like receptor activation, CD40/CD40L interaction, and cytokine priming.